Redirect Notice

Looks like you clickedhttps://www.gilead.com/news-and-press/press-room/press-releases/2020/6/gilead-announces-results-from-phase-3-trial-of-remdesivir-in-patients-with-moderate-covid-19

If you do not want to visit that page, you can close this browser tab.